Ophthalmology · Winter Haven, FL
NPI
1972574408
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
250 Avenue K SW, Suite 200
Winter Haven, FL, 33880
Phone (863) 297-5400
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.3M
50,277 services
Medicare patients, 2024
847
Average age 79
Drug cost, 2024
$683K
1,033 prescriptions
Company payments, 2025
$6,237
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adam S Berger was code J2777 (injection, faricimab-svoa, 0.1 mg), 33,480 times for 125 patients. In total Adam S Berger billed 50,277 services in 48 codes, and Medicare paid $3.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 33,480 | 125 | $27.50 | $921K |
| J2781 Injection, pegcetacoplan, intravitreal, 1 mg | Office | 4,305 | 71 | $117.56 | $506K |
| J2782 Injection, avacincaptad pegol, 0.1 mg | Office | 3,261 | 43 | $86.14 | $281K |
| 92134 Computerized Ophthalmic Imaging | Office | 1,972 | 670 | $27.34 | $54K |
| 67028 Intravitreal Injection | Office | 1,590 | 382 | $92.72 | $147K |
| 99213 Office E&M - Established | Office | 1,314 | 511 | $62.91 | $83K |
| Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 1,128 | 66 | $183.14 | $207K |
| J0178 Injection, aflibercept, 1 mg | Office | 1,033 | 156 | $662.18 | $684K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 616 | 29 | $264.26 | $163K |
| 99214 Office E&M - Established | Office | 543 | 264 | $83.90 | $46K |
| J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 217 | 19 | $161.15 | $35K |
| 92250 Angiography | Office | 181 | 123 | $26.31 | $4,762 |
| J7999 Compounded drug, not otherwise classified | Office | 118 | 71 | $62.46 | $7,371 |
| 99203 Office E&M - New | Office | 83 | 83 | $75.87 | $6,298 |
| 99204 Office E&M - New | Office | 77 | 77 | $108.93 | $8,388 |
By year: 2022 $2.0M for 9,112 services; 2023 $2.7M for 18,819 services; 2024 $3.3M for 50,277 services.
Medicare prescription drug claims, 2024
In 2024, the drug Adam S Berger prescribed most often to Medicare patients was Prednisolone Acetate, with 291 prescriptions and refills. In total Adam S Berger wrote 1,033 Medicare prescriptions that cost $683K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 291 | 364 | 148 | $11K |
| Eylea Aflibercept | 130 | 130 | 26 | $280K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 102 | 208 | 44 | $1,512 |
| Gentamicin Sulfate Generic | 95 | 98 | 87 | $971 |
| Latanoprost Generic | 57 | 72 | 15 | $412 |
| Ketorolac Tromethamine Generic | 52 | 61 | 22 | $764 |
| Izervay Avacincaptad Pegol Sodium/Pf | 43 | 43 | 11 | $157K |
| Brimonidine Tartrate Generic | 38 | 67 | 16 | $265 |
| Syfovre Pegcetacoplan/Pf | 33 | 33 | Under 11 | $118K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 27 | 28 | 12 | $394 |
| Vabysmo Faricimab-Svoa | 22 | 22 | Under 11 | $49K |
| Timolol Maleate Generic | 18 | 27 | Under 11 | $147 |
| Dorzolamide Hcl Generic | 14 | 20 | Under 11 | $290 |
| Atropine Sulfate Generic | 12 | 28 | Under 11 | $358 |
| Cimerli Ranibizumab-Eqrn | 11 | 11 | Under 11 | $17K |
Brand drugs: 589 claims; generic drugs: 444 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adam S Berger $6,237 ($6,237 in general payments such as food, travel and fees) from 15 companies. The largest payer was OnMark, Inc. with $4,891.
| Company | Payments | Amount |
|---|---|---|
| OnMark, Inc. | 11 | $4,891 |
| Alcon Research LLC ALC | 1 | $354 |
| Astellas Pharma US Inc 4503.T | 10 | $332 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $161 |
| Genentech USA, Inc. ROG.SW | 5 | $143 |
| US Oncology Corporate, Inc. | 1 | $123 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 1 | $107 |
| Abbvie Inc. ABBV | 3 | $70.89 |
| Sandoz Inc. SDZ.SW | 1 | $32.12 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $23.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.